Valrubicin Dosage
Medically reviewed by Drugs.com. Last updated on Apr 15, 2024.
Applies to the following strengths: 40 mg/mL
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Urinary Tumor
Usual Adult Dose: 800 mg administered intravesically once a week for six weeks.
Comments:
- Delay administration at least two weeks after transurethral resection and/or fulguration.
- Patients should retain the drug for two hours before voiding, if they are able. At the end of two hours, all patients should void.
Use: For intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Storage requirements:
- Refrigerate
- Do not heat vials.
Reconstitution/preparation techniques: The manufacturer product information should be consulted.
Monitoring:
- Monitor closely for disease recurrence or progression.
- Recommended evaluations include cystoscopy, biopsy, and urine cytology every 3 months.
Patient advice:
- Patients should maintain adequate hydration following treatment.
More about valrubicin
- Check interactions
- Compare alternatives
- Side effects
- During pregnancy
- Drug class: antibiotics/antineoplastics
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.